Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Abcellera Biologics Inc (ABCL)

Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Down 57%, Is AbCellera Biologics a Buy on the Dip?

Wall Street analysts say this drug developer can more than double your money.

LLY : 878.45 (-0.55%)
ABCL : 3.23 (-3.00%)
AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript

ABCL earnings call for the period ending March 31, 2024.

ABCL : 3.23 (-3.00%)
AbCellera Biologics (ABCL) Q4 2023 Earnings Call Transcript

ABCL earnings call for the period ending December 31, 2023.

ABCL : 3.23 (-3.00%)
4 Magnificent Healthcare Stocks to Buy in 2024 and Beyond

Healthcare stocks have underperformed in 2023, but that is expected to change this year.

CNC : 68.93 (-0.07%)
HALO : 49.50 (-0.24%)
ABCL : 3.23 (-3.00%)
HUM : 358.93 (+0.23%)
3 Growth Stocks That Could Go Parabolic in 2024

These innovation-oriented companies could take flight this year.

ABCL : 3.23 (-3.00%)
CERS : 1.7400 (-3.33%)
TSHA : 3.97 (-4.80%)
AbCellera Biologics (ABCL) Q3 2023 Earnings Call Transcript

ABCL earnings call for the period ending September 30, 2023.

ABCL : 3.23 (-3.00%)
Argenx's 28% Surge & Promising Product Propel Investor Confidence

Argenx's chart is forming a bullish base after a 28% jump after positive clinical trials. Analysts believe the immunology specialist is an acquisition target.

ARGX : 387.00 (-0.35%)
ABBV : 168.59 (+1.22%)
ABCL : 3.23 (-3.00%)
ALNY : 160.39 (+0.21%)
AMGN : 298.62 (+0.04%)
ANAB : 23.77 (-1.98%)
AZN : 79.59 (+0.08%)
BMY : 41.20 (-0.68%)
INCY : 62.11 (-0.93%)
REGN : 1,036.52 (+0.97%)
VIE : 53.01 (unch)
AbCellera Biologics (ABCL) Q2 2023 Earnings Call Transcript

ABCL earnings call for the period ending June 30, 2023.

ABCL : 3.23 (-3.00%)
AbCellera Biologics (ABCL) Q1 2023 Earnings Call Transcript

ABCL earnings call for the period ending March 31, 2023.

ABCL : 3.23 (-3.00%)
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Tops Revenue Estimates

AbCellera Biologics Inc. (ABCL) delivered earnings and revenue surprises of -16.67% and 6.76%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

ABCL : 3.23 (-3.00%)
PIRS : 10.09 (+0.90%)

Barchart Exclusives

3 Highest-yielding Tech Stocks to Buy Now
Tech stocks aren't famous for paying dividends. There are, however, a select few that do. Here are the top 3 based on yield. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar